Cornerstone Therapeutics, Inc. (CRTX) Posts Q2 Loss of 17c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
(Provision for) benefit from income taxes: -4.68M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
(Provision for) benefit from income taxes: -4.68M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q2 EPS of ($0.17), $0.15 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $21.47 million versus the consensus estimate of $18.84 million.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Venture Global rises after QatarEnergy supply talks reported
- Accenture shares fall on insider sales and analyst downgrade
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
